ReviewOncoTargets and therapy2018

Subsequent anti-VEGF therapy after first-line anti-EGFR therapy improved overall survival of patients with metastatic colorectal cancer.

Tianzhu Qiu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.